Business Description
Anhui Huaren Health Pharmaceutical Co Ltd
ISIN : CNE100005YT4
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | 6.57 | |||||
Interest Coverage | 11.94 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.23 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.4 | |||||
3-Year EBITDA Growth Rate | 32.6 | |||||
3-Year EPS without NRI Growth Rate | 1 | |||||
3-Year FCF Growth Rate | -41.4 | |||||
3-Year Book Growth Rate | 32.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.56 | |||||
9-Day RSI | 38.96 | |||||
14-Day RSI | 42.69 | |||||
6-1 Month Momentum % | 24.6 | |||||
12-1 Month Momentum % | -19.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.55 | |||||
Days Inventory | 102 | |||||
Days Sales Outstanding | 42.44 | |||||
Days Payable | 144.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 0.87 | |||||
5-Year Yield-on-Cost % | 0.87 | |||||
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | -9.52 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.4 | |||||
Operating Margin % | 4.95 | |||||
Net Margin % | 3.07 | |||||
FCF Margin % | 0.3 | |||||
ROE % | 6.86 | |||||
ROA % | 2.85 | |||||
ROIC % | 6.65 | |||||
ROC (Joel Greenblatt) % | 20.47 | |||||
ROCE % | 7.41 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.02 | |||||
PE Ratio without NRI | 31.81 | |||||
PEG Ratio | 0.74 | |||||
PS Ratio | 1.05 | |||||
PB Ratio | 2.28 | |||||
Price-to-Tangible-Book | 5.11 | |||||
Price-to-Free-Cash-Flow | 171.52 | |||||
Price-to-Operating-Cash-Flow | 19.96 | |||||
EV-to-EBIT | 23.63 | |||||
EV-to-EBITDA | 23.63 | |||||
EV-to-Revenue | 1.08 | |||||
EV-to-FCF | 364.67 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.69 | |||||
Price-to-Graham-Number | 2.67 | |||||
Earnings Yield (Greenblatt) % | 4.23 | |||||
FCF Yield % | 0.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Anhui Huaren Health Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 4,388.147 | ||
EPS (TTM) (Â¥) | 0.331 | ||
Beta | 0 | ||
Volatility % | 38.84 | ||
14-Day RSI | 42.69 | ||
14-Day ATR (Â¥) | 0.562463 | ||
20-Day SMA (Â¥) | 12.2845 | ||
12-1 Month Momentum % | -19.03 | ||
52-Week Range (Â¥) | 9.3 - 16.3 | ||
Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Anhui Huaren Health Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Anhui Huaren Health Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Anhui Huaren Health Pharmaceutical Co Ltd Frequently Asked Questions
What is Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)'s stock price today?
When is next earnings date of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)?
Does Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |